Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-β-lactamase gene

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1325-1330

  Siarkou, Victoria I ^a   Vitti, Danai ^b   Protonotariou, Efthimia ^b   Ikonomidis, Alexandros ^c   Sofianou, Danai ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFTAZIDIME; GENOMIC DNA; METALLO BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; EPIDEMIC; GENE SEQUENCE; GREECE; INTEGRON; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; TRANSPOSON; UNIVERSITY HOSPITAL;

BETA-LACTAMASES; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 65649085283     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01230-08     Document Type: Article

References (39)

1. Aloush, V., S. Navon-Venezia, Y. Seigman-Igra, S. Cabili, and Y. Carmeli. 2006. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother. 50:43-48. (Pubitemid 43042900)
2. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurakawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-beta-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Micro-biol. 38:40-43. (Pubitemid 30043261)
3. Bendtaen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. MoI. Biol. 340:783-795. (Pubitemid 38829638)
4. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Cornaglia, G., M. Akova, G. Amicosante, R. Cantón, R, Cauda, J.-D. Doc-quier, M. Edelstein, J.-M. Frère, M. Fuzi, M. Galleni, H. Giamarellou, M. Gniadkowski, R. Koncan, B. Libisch, F. Luzzaro, V. Miriagou, F. Navarro, P. Nordmann, L. Pagani, L. Peixe, L. Poirel, M. Souli, E. Tacconelli, A. Vato-poulos, and G. M. Rossolini on behalf of the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). 2007. Metallo-β-lactama-ses as emerging resistance determinants in gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388. (Pubitemid 46349587)
6. Corvee, S., L. Poirel, E. Espaze, C. Giraudeau, H. Drugeon, and P. Nord-mann. 2008. Long-term evolution of a nosocomial outbreak oí Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J. Hosp. Infect. 68:73-82.
7. Falagas, M. E., and P. Kopterides. 2006. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J. Hosp. Infect. 64:7-15. (Pubitemid 44161380)
8. Garau, G., I. Garcia-Saez, C. Bebrone, C. Anne, P. Mercuri, M. Galleni, J. M. Frere, and O. Dideberg. 2004. Update of the standard numbering scheme for class B ß-lactamases. Antimicrob. Agents Chemother. 48:2347-2349. (Pubitemid 38823395)
9. Hall, R. M., and C. M. Collis. 1998. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and intégrons. Drug Resist. Updat. 1:109-119.
10. Kaufmann, M. E. 1998. Pulsed-fleld gel electrophoresis. Methods MoI. Med. 15:17-31.
11. Kumar, S., K. Tamura, and N. Masatoshi. 2004. MEG A3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
12. Lagatolla, C, E. Edalucci, L. Dolzani, M. L. Riccio, F. De Luca, E. Medessi, G. M. Rossolini, and E. A. Tonin. 2006. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity J. Clin. Microbiol. 44:2348-2353. (Pubitemid 44092397)
13. Levesque, C, L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of intégrons reveals several novel combinations of resistance genes. Antimi-crob. Agents Chemother. 39:185-191.
14. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640. (Pubitemid 34165326)
15. Lombardi, G., F. Luzzaro, J. D. Docquier, M. L. Riccio, M. Perlili, A. Coli, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2002. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-I metallo-ß -lactamase. J. Clin. Microbiol. 40:4051-4055. (Pubitemid 35285788)
16. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Esche-richia coli with a self-transferable, multi-resistant plasmid coding for the métallo-ß-lactamase VIM-I. Antimicrob. Agents Chemother. 47:395-397. (Pubitemid 36070394)
17. Pai, H., J. Kim, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical iso-lates. Antimicrob. Agents Chemother. 45:480-484. (Pubitemid 32105284)
18. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing métallo-ß-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Che-mother. 44:891-897. (Pubitemid 30165266)
19. Poirel, L., and P. Nordmann. 2002. Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr. Pharm. Biotechnol. 3:117-127. (Pubitemid 34520928)
20. Poirel, L., T. Lambert, S. Turkoglii, E. Ronco, J.-L. Gaillard, and P. Nord-mann. 2001. Characterization of class 1 intégrons from Pseudomonas aerugi-nosa that contain the 6íflVIM-2 carbapenem-hydrolyzing ß-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45:546-552. (Pubitemid 32106716)
21. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20:440-458.
22. Quinteira, S., J. C. Sousa, and L. Peixe. 2005. Characterization of InIOO, a new integran carrying a métallo-ß-lactamase and a carbenicillinase, from Pseudomonas aeruginosa Antimicrob. Agents Chemother. 49:451-453. (Pubitemid 40065831)
23. Riccio, M. L., L. Pallecchi, J. D. Docquier, S. Cresti, M. R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G. M. Rossolini. 2005. Clonal relatedness and conserved integran structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-I metallo-ß-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110. (Pubitemid 40065779)
24. Riccio, M. L., L. Pallecchi, R. Fontana, and G. M. Rossolini. 2001. In70 of plasmid pAX22, a MaVIM.1-containing integron carrying a new aminoglyco-side phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45: 1249-1253. (Pubitemid 32231008)
25. Rice, L. B., and R. A. Bonomo. 2005. Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents, p. 441-508./« V. Lorian (ed.), Antibiotics in laboratory medicine, 5th ed. The Williams & Wilkins Co., Baltimore, MD.
26. Rossolini, G. M., and E. Mantengoli. 2005. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microbiol. Infect. 11:17-32. (Pubitemid 40946169)
27. Sambrook, J., and D. W. Russell. 2001. Preparation of plasmid DNA by alkaline lysis with SDS: minipreparation, section 1.32. In Molecular cloning: a laboratory manual, vol.1, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Sligl, W., G. Taylor, and P. G. Brindley. 2006. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int. J. Infect. Dis. 10: 320-325. (Pubitemid 43850827)
29. Stokes, H. W., D. B. O'Gorman, G. D. Recchia, M. Parsekhian, and R. M. Hall. 1997. Structure and function of 59-base element recombination sites associated with mobile gene cassettes. MoI. Microbiol. 26:731-745. (Pubitemid 27489335)
30. Tennstedt, T., R. Szczepanowski, S. Braun, A. Puehler, and A. Schlueter. 2003. Occurrence of integron-associated resistance gene cassettes located on antibiotic resistance plasmids isolated from a wastewater treatment plant. FEMS Microbiol. Ecol. 45:239-252. (Pubitemid 36959923)
31. Tenover, F. C, R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-fleld gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680. (Pubitemid 24354800)
33. Toleman, M. A, D. Biedenbach, D. Bennett, R. N. Jones, and T. R. Walsh. 2003. Genetic characterization of a novel metallo-ß-lactamase gene, W«IMP-I3. har-boured by a novel Tn5052-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J. Antimicrob. Chemother. 52:583-590. (Pubitemid 37258417)
34. Toleman, M. A., D. Biedenbach, D. M. Bennett, R. N. Jones, and T. R. Walsh. 2005. Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 55:61-70.
35. Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, J. P. Quinn, and Colombian Nosocomial Resistance Study Group. 2007. First identifica-tion of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing ß-lactamase. Antimicrob. Agents Chemother. 51:1553-1555. (Pubitemid 46586851)
36. Walsh, F., and S. G. Arrives. 2007. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J. Chemother. 19:376-381. (Pubitemid 47236515)
37. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
38. Yan, J. J., P. R. Hsueh, W. C. Ko, K. T. Luh, S. H. Tsai, H. M. Wu, and J. J. Wu. 2001. Metallo-beta-lactamases in clinical Pseudomonas isolates in Tai-wan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228. (Pubitemid 32664460)
39. Zavascki, A. P., R. P. Cruz, and L. Z. Goldani. 2005. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J. Hosp. Infect. 59:96-101. (Pubitemid 40058034)